Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has entered into an asset purchase agreement with antibody engineering company ImaginAb, Inc. (ImaginAb) to ...
Stockhead on MSN2h
Health Check: Telix to acquire next-gen therapeutics and biologics platform
Telix Pharmaceuticals (ASX:TLX) enters into an asset purchase agreement with antibody engineering company ImaginAb.
capitalbrief9h
Telix agrees $73m asset acquisition with US biotech ImaginAb
Telix Pharmaceuticals has reached a deal with US biotech ImaginAb to acquire a pipeline of next-generation therapeutic ...
Up 120% in a year, ASX 200 healthcare stock dips on US acquisition
The ASX 200 healthcare company announced a strategic new US acquisition. The post Up 120% in a year, ASX 200 healthcare stock ...